2017-06-082017-06-082006https://hdl.handle.net/1813/51243Question and answer sessionen-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalAgricultural biotechnologytechnology transferintellectual propertyregulationgenetic engineeringpublic goodbioethicsskill developmentpublic funding, industry fundingQ&A: Bridging the gap: from laboratory to commercial productbook chapter